Appendix B
Disclosure of Unavoidable Conflict of Interest
The conflict of interest policy of the National Academies of Sciences, Engineering, and Medicine (http://www.nationalacademies.org/coi) prohibits the appointment of an individual to a committee authoring a Consensus Study Report if the individual has a conflict of interest that is relevant to the task to be performed. An exception to this prohibition is permitted if the National Academies determines that the conflict is unavoidable and the conflict is publicly disclosed. A determination of a conflict of interest for an individual is not an assessment of that individual’s actual behavior or character or ability to act objectively despite the conflicting interest.
Dr. Florian Krammer has a conflict of interest in relation to his service on the Committee on Vaccine Research and Development Recommendations for Advancing Pandemic and Seasonal Influenza Vaccine Preparedness and Response because he has consulting relationships with the vaccine manufacturing companies Avimex and Seqirus.
The National Academies has concluded that in order for the committee to accomplish the tasks for which it was established, its membership must include at least one person with current experience in biotechnology, novel vaccine platforms, and applied industry experience in vaccine research and development. As described in his biographical summary, Dr. Krammer has extensive current experience in leveraging novel technologies to develop vaccines and direct experience working with influenza manufacturing companies developing practical and effective vaccine platforms.
This page intentionally left blank.